MariMed CEO Levine converts award to 30,625 shares

The remaining RSUs from the grant will vest in two equal installments on January 15 and April 15, 2027.

Rhea-AI Filing Summary

Marimed Inc. President and CEO Jon R. Levine converted 30,625 restricted stock units into 30,625 common shares on October 15, 2026, on a one-for-one basis. The issuer withheld 8,989 shares to satisfy tax withholding obligations tied to vesting, at a reported $0.06 per share. 61,250 RSUs remained following the transaction. A separate holding entry lists 6,684,640 common shares held by Levine’s spouse; Levine disclaims beneficial ownership of those shares.

Insider Trade Summary

30,625 shares exercised/converted

Exercise 4 txns

Insider Levine Jon R

Role President and CEO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units (RSU) F1, F4	30,625	$0.00	$0.00
Exercise	Common stock F1	30,625	$0.00	$0.00
Tax Withholding	Common stock F2	8,989	$0.06	$539.34
holding	Common stock F3	--	--	--

Holdings After Transaction: Restricted Stock Units (RSU) — 61,250 contracts (Direct); Common stock — 21,387,793 shares (Direct); Common stock — 6,684,640 shares (Indirect, By Spouse)

Footnotes (4)

1. F1. RSUs convert to shares of common stock on a one-for-one basis.
2. F2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
3. F3. These shares are held by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
4. F4. The RSUs were granted on April 15, 2026; the remaining RSUs under this grant will vest in two equal installments on each of January 15, 2027 and April 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Key Figures

RSUs converted: 30,625 RSUs Common shares acquired: 30,625 shares Shares withheld for tax obligations: 8,989 shares +3 more

6 metrics

RSUs converted 30,625 RSUs October 15, 2026

Common shares acquired 30,625 shares October 15, 2026

Shares withheld for tax obligations 8,989 shares In connection with RSU vesting on October 15, 2026

Reported price per share $0.06 per share Shares withheld for tax obligations

RSUs following transaction 61,250 RSUs Reported after the October 15, 2026 transaction

Spouse-held common shares 6,684,640 shares Levine disclaims beneficial ownership

Key Terms

one-for-one basis, tax withholding obligations, award agreement

3 terms

one-for-one basis technical

"RSUs convert to shares of common stock on a one-for-one basis."

tax withholding obligations financial

"to satisfy tax withholding obligations in connection with the vesting of RSUs"

award agreement financial

"in accordance with the terms of an award agreement"

An award agreement is a legal contract that spells out the terms of a pay or equity grant—such as stock options, restricted shares, or cash bonuses—given to an employee, director or consultant. It describes what is being granted, any conditions for keeping it (for example, earning it over time or meeting performance targets), and what happens if the person leaves or breaks rules. Investors care because these agreements affect company costs, potential share dilution and how executives are motivated and rewarded.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MRMD shares did Jon R. Levine receive from RSUs?

Marimed Inc. President and CEO Jon R. Levine converted 30,625 RSUs into 30,625 common shares on October 15, 2026, consistent with the one-for-one conversion term. The reported post-transaction RSU balance was 61,250.

How many MRMD shares were withheld for taxes?

The issuer withheld 8,989 common shares on October 15, 2026, to satisfy tax withholding obligations in connection with RSU vesting. The reported price per share was $0.06.

When do Jon R. Levine’s remaining RSUs vest?

The remaining RSUs under the grant will vest in two equal installments on January 15, 2027 and April 15, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/15/2026 - 06:51 PM EDT Accepted by SEC EDGAR 10/15/2026 - 06:50 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Levine Jon R

(Last) (First) (Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD, MASSACHUSETTS 02062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	10/15/2026		M		30,625	A	$0(1)	21,396,782	D
Common stock	10/15/2026		F		8,989(2)	D	$0.06	21,387,793	D
Common stock								6,684,640	I	By Spouse(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSU)	(1)	10/15/2026		M			30,625	(4)	(4)	Common Stock, par value $.001 per share	30,625	$0	61,250	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

3. These shares are held by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

4. The RSUs were granted on April 15, 2026; the remaining RSUs under this grant will vest in two equal installments on each of January 15, 2027 and April 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Remarks:

	/s/ Jon R. Levine	10/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)